Arab Journal of Gastroenterology
Volume 11, Issue 1 , Pages 30-34 , March 2010

Insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection

  • Mohamed Yaqoot Abdel-Azziz

      Affiliations

    • Internal Medicine Department, Faculty of Medicine, Mansoura University Hospital, Al Mansoura, Egypt
    • Corresponding Author InformationCorresponding author. Tel.: +20 502360885.
    • ,
  • Kkaled Refaat Zalata

      Affiliations

    • Pathology Department, Faculty of Medicine, Mansoura University Hospital, Al Mansoura, Egypt
    • ,
  • Mahmoud M. El-Bendary

      Affiliations

    • Tropical Medicine Department, Faculty of Medicine, Mansoura University Hospital, Al Mansoura, Egypt

Received 31 August 2009 ,Accepted 5 January 2010.

References 

  1. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000;20(1):1–16
  2. El Sayed NM, Gomatos PJ, Rodier GR, et al. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt. Am J Trop Med Hyg. 1996;55(2):179–184
  3. Abdel Wahab MF, Zakaria S, Kamel M, et al. High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg. 1994;51(5):563–567
  4. Marcellin P. Hepatitis C: the clinical spectrum of the disease. J Hepatol. 1999;31(Suppl. 1):9–16
  5. Allison ME, Wreghitt T, Palmer CR, et al. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol. 1994;21(6):1135–1139
  6. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. 2000;133(8):592–599
  7. El Zayadi AR, Selim OE, Hamdy H, et al. Association of chronic hepatitis C infection and diabetes mellitus. Trop Gastroenterol. 1998;19(4):141–144
  8. Grimbert S, Valensi P, Levy Marchal C, et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol. 1996;20(6–7):544–548
  9. Warram JH, Martin BC, Krolewski AS, et al. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med. 1990;113(12):909–915
  10. Song Y, Manson JE, Tinker L, et al. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic Cohort of women: the women’s health initiative observational study. Diabetes Care. 2007;30(7):1747–1752
  11. Monto A, Alonzo J, Watson JJ, et al. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus and alcohol. Hepatology. 2002;36(3):729–736
  12. Czaja AJ, Carpenter HA, Santrach PJ, et al. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol. 1998;29(2):198–206
  13. Ratziu V, Munteanu M, Charlotte F, et al. Fibrogenic impact of high serum glucose in chronic hepatitis C. J Hepatol. 2003;39(6):1049–1055
  14. Martinot Peignoux M, Boyer N, Cazals Hatem D, et al. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology. 2001;34(5):1000–1005
  15. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191–2192
  16. Hui JM, Sud A, Farrell GC, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology. 2003;125(6):1695–1704
  17. Friedman SL. Liver fibrosis – from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38–S53
  18. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Lancet. 1997;349(9055):825–832
  19. Puoti C, Magrini A, Stati T, et al. Clinical, histological and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology. 1997;26(6):1393–1398
  20. Schmidt AM, Hori O, Brett J, et al. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb. 1994;14(10):1521–1528
  21. Fehrenbach H, Weiskirchen R, Kasper M, et al. Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology. 2001;34(5):943–952
  22. Fukui M, Kitagawa Y, Nakamura N, et al. Response to oncul: Insulin sensitivity in patients with chronic hepatitis C virus infection. Diabetes Care. 2002;25(10):1900-1–1901-2discussion
  23. Maeno T, Okumura A, Ishikawa T, et al. Mechanisms of increased insulin resistance in non-cirrhotic patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol. 2003;18(12):1358–1363
  24. El Sammak M, Refai W, El Sawaf A, et al. Elevated serum tumor necrosis factor alpha and ferritin may contribute to the insulin resistance found in HCV positive Egyptian patients. Curr Med Res Opin. 2005;21(4):527–534
  25. Yoneda M, Saito S, Ikeda T, et al. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J Viral Hepatol. 2007;14(9):600–607
  26. Kawaguchi T, Yoshida T, Harada M, et al. Hepatitis C virus Down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol. 2004;165(5):1499–1508
  27. Hui CK, Belaye T, Montegrande K, et al. A comparison in the progression of liver fibrosis in chronic hepatitis C between persistently normal and elevated transaminase. J Hepatol. 2003;38(4):511–517
  28. Fartoux L, Poujol Robert A, Guechot J, et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut. 2005;54(7):1003–1008
  29. Paradis V, Perlemuter G, Bonvoust F, et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology. 2001;34(4 Pt 1):738–744
  30. D’Souza R, Sabin CA, Foster GR. Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy. Am J Gastroenterol. 2005;100(7):1509–1515

PII: S1687-1979(10)00005-5

doi: 10.1016/j.ajg.2010.01.004

Arab Journal of Gastroenterology
Volume 11, Issue 1 , Pages 30-34 , March 2010

Article Tools

* Image Usage & Resolution